1.78

11.95% 0.19

After Hours: 1.82 0.04 +2.25%

Aldeyra Therapeutics Inc (ALDX)

Overview News Price History Option Chain Financials Discussions Forecast

Aldeyra Therapeutics Inc stock is traded at $1.78, with a volume of 2.25M. It is up +11.95% in the last 24 hours and down -64.47% over the past month. Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Previous Close:

$1.59

Open:

$1.6

24h Volume:

2.25M

Relative Volume:

0.81

Market Cap:

$107.13M

Revenue:

Net Income/Loss:

$-33.85M

P/E Ratio:

-3.1571

EPS:

-0.5638

Net Cash Flow:

$-33.35M

1W Performance:

+7.23%

1M Performance:

-64.47%

6M Performance:

-66.98%

1Y Performance:

-5.82%

1-Day Range:

$1.60

$1.8079

1-Week Range:

$1.48

$1.8079

52-Week Range:

$1.07

$6.175

Aldeyra Therapeutics Inc Stock (ALDX) Company Profile

Name

Aldeyra Therapeutics Inc

Sector

Healthcare (1106)

Industry

Biotechnology (623)

Phone

781-761-4904

Address

131 HARTWELL AVENUE, LEXINGTON, MA

Employee

Twitter

@aldeyraaldx

Next Earnings Date

2025-08-08

Latest SEC Filings

ALDX's Discussions on Twitter

Compare ALDX vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ALDX Aldeyra Therapeutics Inc	1.78	107.13M	0	-33.85M	-33.35M	-0.5638
VRTX Vertex Pharmaceuticals Inc	436.27	110.97B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	748.87	79.17B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	799.65	49.73B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	322.11	42.98B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	309.66	34.37B	5.36B	287.73M	924.18M	2.5229

Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-18-26	Downgrade	H.C. Wainwright	Buy → Neutral
Apr-03-24	Upgrade	Oppenheimer	Perform → Outperform
Apr-02-24	Resumed	H.C. Wainwright	Buy
Apr-27-22	Resumed	H.C. Wainwright	Buy
Feb-08-21	Initiated	H.C. Wainwright	Buy
Dec-16-20	Initiated	Berenberg	Buy
Oct-30-20	Initiated	Jefferies	Buy
Oct-16-20	Initiated	BTIG Research	Buy
Sep-22-20	Initiated	Alliance Global Partners	Buy
May-12-20	Initiated	Oppenheimer	Outperform
Dec-04-18	Initiated	Citigroup	Buy
Sep-26-18	Reiterated	Cantor Fitzgerald	Overweight
Sep-13-18	Initiated	Janney	Buy
Jan-26-18	Initiated	Seaport Global Securities	Buy
Sep-26-16	Initiated	H.C. Wainwright	Buy
Jul-01-16	Initiated	Stifel	Buy
Jul-01-15	Initiated	Canaccord Genuity	Buy
Mar-25-15	Initiated	Chardan Capital Markets	Buy
Mar-20-15	Reiterated	H.C. Wainwright	Buy
Nov-18-14	Initiated	H.C. Wainwright	Buy
Jun-19-14	Initiated	Aegis Capital	Buy

View All

Aldeyra Therapeutics Inc Stock (ALDX) Latest News

12:00 PM

Bronstein, Gewirtz & Grossman LLC Urges Aldeyra - GlobeNewswire

12:00 PM

10:41 AM

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in ... - Bluefield Daily Telegraph

10:41 AM

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.

10:41 AM

10:01 AM

ROSEN, THE FIRST FILING FIRM, Encourages Trip.com Group Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.

10:01 AM

04:01 AM

Rosen Law Firm Encourages Aldeyra Therapeutics Investors to Secure Counsel Before Upcoming Deadline - National Today

04:01 AM

Apr 11, 2026

Did You Lose Money Investing in Aldeyra Therapeutics, Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against ADLX - ACCESS Newswire

Apr 11, 2026

Apr 10, 2026

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - The Killeen Daily Herald

Apr 10, 2026

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire

Apr 10, 2026

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire Inc.

Apr 10, 2026

Portnoy Law Firm Announces Class Action on Behalf of Aldeyra Therapeutics, Inc. Investors - GlobeNewswire

Apr 10, 2026

2026-04-10 | Did You Lose Money Investing in Aldeyra Therapeutics, Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against ADLX | NDAQ:ALDX | Press Release - Stockhouse

Apr 10, 2026

ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra ... - Bluefield Daily Telegraph

Apr 10, 2026

ALDX Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire

Apr 10, 2026

Apr 09, 2026

ROSEN, A LEADING AND RANKED FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure ... - Bluefield Daily Telegraph

Apr 09, 2026

ROSEN, A LEADING AND RANKED FIRM, Encourages Aldeyra - GlobeNewswire

Apr 09, 2026

ROSEN, A LEADING AND RANKED FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.

Apr 09, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming DeadlinesALDX - Finansavisen

Apr 09, 2026

ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 09, 2026

BTIG Maintains Buy on Aldeyra Therapeutics (ALDX) March 2026 - Meyka

Apr 09, 2026

Published on: 2026-04-09 11:55:34 - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bronstein, Gewirtz & Grossman, LLC (ALDX) And Encourages Investors to Reach Out - ACCESS Newswire

Apr 08, 2026

Is Aldeyra Therapeutics Inc stock trending bullishEarnings Risk Summary & Weekly Breakout Watchlists - baoquankhu1.vn

Apr 08, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra ... - Black Hills Pioneer

Apr 08, 2026

ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit -- The Gross Law Firm - Sahm

Apr 08, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Apr 08, 2026

Apr 07, 2026

ALDX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 07, 2026

ALDX Shareholder Alert: Investors With Losses May Seek to Lead t - GuruFocus

Apr 07, 2026

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics Securities Fraud Lawsuit - National Today

Apr 07, 2026